デフォルト表紙
市場調査レポート
商品コード
1553517

臨床リスクグルーピングソリューションの市場規模、シェア、動向分析レポート:製品別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年

Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software, Services), By Application (Population Health Management, Chronic Disease Management), By End Use, By Region, And Segment Forecasts, 2024 - 2030


出版日
ページ情報
英文 120 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.81円
臨床リスクグルーピングソリューションの市場規模、シェア、動向分析レポート:製品別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2024年08月20日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床リスクグルーピングソリューションン市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の臨床リスクグルーピングソリューション市場規模は2030年までに16億7,000万米ドルに達し、2024年から2030年までのCAGRは13.13%で拡大すると予測されています。

この市場には、ヘルスケア環境における患者のリスクを効果的に評価・管理するために設計された様々なツールや技術が含まれています。

データ分析と技術の進歩は、市場を前進させる上で極めて重要です。人工知能(AI)と機械学習(ML)を臨床リスクグルーピングソリューションンに組み込むことで、転帰を予測する能力が大幅に向上し、ヘルスケア提供者はより良い情報に基づいた意思決定を行うことができるようになります。

ヘルスケアプロバイダーが費用を抑制しながら患者の転帰を向上させようと努力する中、包括的な集団健康管理ソリューションの必要性がますます高まっています。これらのソリューションにより、ヘルスケア機関は患者データを効果的に分析し、リスクの高い患者を特定し、予防戦略を実施することができます。

臨床リスクグルーピングソリューションン市場レポート・ハイライト

  • 製品別では、ソフトウェアが2023年に77.46%の最大市場シェアを占めました。電子カルテ(EHR)と高度な分析ツールの利用が増加していることから、患者を臨床リスクに応じて正確に分類し、個別化された治療計画をサポートし、患者の転帰を向上させるソフトウェアソリューションに対する需要が高まっています。
  • アプリケーション別では、集団健康管理が2023年に33.20%の最大市場シェアを占めました。このセグメントは、電子カルテ、請求データ、健康の社会的決定要因などの多様なソースからの患者データを統合し、高リスクの個人をピンポイントで特定し、全体的な健康転帰を高めるためにカスタマイズされた介入策を考案します。
  • 最終用途に基づくと、病院と診療所が2023年に48.30%の最大収益シェアで市場を独占しました。これらの機関は、臨床リスクグルーピングソリューションンを採用して、健康状態、治療要件、潜在的リスクに応じて患者を分類し、患者管理を改善しコストを削減できる個別化ケアプランを可能にします。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床リスクグルーピングソリューション市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 臨床リスクグルーピングソリューション市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 臨床リスクグルーピングソリューション市場:製品別推定・動向分析

  • 世界の臨床リスクグルーピングソリューション市場:製品別ダッシュボード
  • 世界の臨床リスクグルーピングソリューション市場:製品別変動分析
  • 製品別収益
  • ソフトウェア
  • サービス

第5章 臨床リスクグルーピングソリューション市場:用途別推定・動向分析

  • 世界の臨床リスクグルーピングソリューション市場:用途別ダッシュボード
  • 世界の臨床リスクグルーピングソリューション市場:用途別変動分析
  • 世界の臨床リスクグルーピングソリューション市場:用途別収益
  • 集団健康管理
    • 市場推計・予測2018~2030年
  • 慢性疾患の管理
    • 市場推計・予測2018~2030年
  • 臨床意思決定支援
    • 市場推計・予測2018~2030年
  • 不正行為の検出と防止
    • 市場推計・予測2018~2030年
  • その他
    • 市場推計・予測2018~2030年

第6章 臨床リスクグルーピングソリューション市場:最終用途別推定・動向分析

  • 世界の臨床リスクグルーピングソリューション市場:最終用途別ダッシュボード
  • 世界の臨床リスクグルーピングソリューション市場:最終用途別変動分析
  • 最終用途別収益
  • 病院・クリニック
  • 外来手術センター
  • 長期ケアセンター
  • その他

第7章 臨床リスクグルーピングソリューション市場:製品、用途、最終用途別の地域推定・動向分析

  • 地域ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年:
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店およびチャネルパートナーのリスト
    • 主要企業の市場シェア分析、2023年
    • Conduent Inc.
    • HBI Solutions
    • 3M
    • Cerner(Oracle)
    • Optum Inc.
    • Reveleer
    • Nuance Communications, Inc.
    • Lightbeam
    • Health Catalyst
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Clinical Risk Grouping Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe Clinical Risk Grouping Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Germany Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 22 UK Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 23 UK Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 26 France Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 27 France Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 29 Italy Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 32 Spain Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Denmark Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 35 Denmark Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 38 Sweden Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Norway Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 41 Norway Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Clinical Risk Grouping Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 48 China Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 49 China Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Japan Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 51 Japan Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 54 India Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 55 India Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 60 Australia Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 63 Thailand Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America Clinical Risk Grouping Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 66 Latin America Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 67 Latin America Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 68 Latin America Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Brazil Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 70 Brazil Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 71 Brazil Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 75 MEA Clinical Risk Grouping Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 77 MEA Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 78 MEA Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Clinical Risk Grouping Solutions market: market outlook
  • Fig. 7 Clinical Risk Grouping Solutions competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Clinical Risk Grouping Solutions market driver impact
  • Fig. 11 Clinical Risk Grouping Solutions market restraint impact
  • Fig. 12 Clinical Risk Grouping Solutions market: Product movement analysis
  • Fig. 13 Clinical Risk Grouping Solutions market: Product outlook and key takeaways
  • Fig. 14 Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Private cloud market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Public cloud market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Hybrid cloud market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Clinical Risk Grouping Solutions market: Application movement analysis
  • Fig. 20 Clinical Risk Grouping Solutions market: Application outlook and key takeaways
  • Fig. 21 Population health management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Chronic disease management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Clinical decision support market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Fraud detection and prevention market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Clinical Risk Grouping Solutions market: End Use movement analysis
  • Fig. 27 Clinical Risk Grouping Solutions market: End Use outlook and key takeaways
  • Fig. 28 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Ambulatory surgical centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Long term care centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Global Clinical Risk Grouping Solutions market: Regional movement analysis
  • Fig. 33 Global Clinical Risk Grouping Solutions market: Regional outlook and key takeaways
  • Fig. 34 Global Clinical Risk Grouping Solutions market share and leading players
  • Fig. 35 North America, by country
  • Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. key country dynamics
  • Fig. 38 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Canada key country dynamics
  • Fig. 40 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico key country dynamics
  • Fig. 42 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 UK key country dynamics
  • Fig. 45 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Germany key country dynamics
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 France key country dynamics
  • Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy key country dynamics
  • Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Spain key country dynamics
  • Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark key country dynamics
  • Fig. 55 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden key country dynamics
  • Fig. 57 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Norway key country dynamics
  • Fig. 59 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 China key country dynamics
  • Fig. 62 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Japan key country dynamics
  • Fig. 64 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 India key country dynamics
  • Fig. 66 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Thailand key country dynamics
  • Fig. 68 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 South Korea key country dynamics
  • Fig. 70 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Australia key country dynamics
  • Fig. 72 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil key country dynamics
  • Fig. 75 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina key country dynamics
  • Fig. 77 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 South Africa key country dynamics
  • Fig. 80 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Saudi Arabia key country dynamics
  • Fig. 82 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 UAE key country dynamics
  • Fig. 84 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Kuwait key country dynamics
  • Fig. 86 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Market share of key market players- Clinical Risk Grouping Solutions market
目次
Product Code: GVR-4-68040-421-6

Clinical Risk Grouping Solution Market Growth & Trends:

The global clinical risk grouping solution market size is anticipated to reach USD 1.67 billion by 2030 and is anticipated to expand at a CAGR of 13.13% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market encompasses various tools and technologies designed to assess and manage patient risk within healthcare settings effectively.

The progress made in data analytics and technology is crucial for propelling the market forward. Incorporating artificial intelligence (AI) and machine learning (ML) into clinical risk grouping solutions significantly improves their ability to predict outcomes, enabling healthcare providers to make better-informed decisions.

As healthcare providers strive to enhance patient outcomes while controlling expenses, the necessity for comprehensive population health management solutions has become increasingly important. These solutions empower healthcare organizations to analyze patient data effectively, pinpoint high-risk individuals, and implement preventive strategies.

Clinical Risk Grouping Solution Market Report Highlights:

  • Based on product, software held the largest market share of 77.46% in 2023. The rising use of electronic health records (EHRs) and advanced analytics tools has driven the demand for software solutions to accurately classify patients according to their clinical risks, support personalized treatment plans, and enhance patient outcomes.
  • Based on application, Population health management held the largest market share of 33.20% in 2023. This segment consolidates patient data from diverse sources, such as electronic health records, claims data, and social determinants of health, to pinpoint high-risk individuals and devise customized interventions to enhance overall health outcomes.
  • Based on end use, hospitals and clinic dominated the market with the largest revenue share of 48.30% in 2023.These institutions employ clinical risk grouping solutions to classify patients according to their health conditions, treatment requirements, and potential risks, enabling personalized care plans that can improve patient management and lower costs.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Risk Grouping Solutions Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising consumer awareness regarding risk management
      • 3.2.1.2. Implementation of big data solutions
      • 3.2.1.3. Increasing focus on AI & Machine Learning
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Patient Data Privacy Concerns
  • 3.3. Clinical Risk Grouping Solutions Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Clinical Risk Grouping Solutions Market: Product Estimates & Trend Analysis

  • 4.1. Global Clinical Risk Grouping Solutions Market: Product Dashboard
  • 4.2. Global Clinical Risk Grouping Solutions Market: Product Movement Analysis
  • 4.3. Global Clinical Risk Grouping Solutions Market Estimates and Forecasts, by Product, Revenue (USD Million)
  • 4.4. Software
    • 4.4.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Private cloud
      • 4.4.2.1. Private cloud market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Public cloud
      • 4.4.3.1. Public cloud market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Hybrid cloud
      • 4.4.4.1. Hybrid cloud market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Clinical Risk Grouping Solutions Market: Application Estimates & Trend Analysis

  • 5.1. Global Clinical Risk Grouping Solutions Market: Application Dashboard
  • 5.2. Global Clinical Risk Grouping Solutions Market: Application Movement Analysis
  • 5.3. Global Clinical Risk Grouping Solutions Market by Application, Revenue
  • 5.4. Population health management
    • 5.4.1. Population health management market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Chronic disease management
    • 5.5.1. Chronic disease management market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Clinical decision support
    • 5.6.1. Clinical decision support market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Fraud detection and prevention
    • 5.7.1. Fraud detection and prevention market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Other
    • 5.8.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Clinical Risk Grouping Solutions Market: End Use Estimates & Trend Analysis

  • 6.1. Global Clinical Risk Grouping Solutions Market: End Use Dashboard
  • 6.2. Global Clinical Risk Grouping Solutions Market: End Use Movement Analysis
  • 6.3. Global Clinical Risk Grouping Solutions Market Estimates and Forecasts, By End Use, Revenue (USD Million)
  • 6.4. Hospitals & Clinics
    • 6.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Ambulatory surgical centers
    • 6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Long term care centers
    • 6.6.1. Long term care centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Clinical Risk Grouping Solutions Market: Regional Estimates & Trend Analysis by Product, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Vendor Landscape
    • 8.2.1. List of key distributors and channel partners
    • 8.2.2. Key company market share analysis, 2023
    • 8.2.3. Conduent Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. HBI Solutions
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. 3M
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Cerner (Oracle)
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Optum Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Reveleer
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Nuance Communications, Inc.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Lightbeam
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Health Catalyst
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives